Works matching DE "PHARMACEUTICAL industry trials %26 litigation"

Results: 51

Taking the "Product" Out of Product Liability: Litigation Risks and Business Implications of Innovator and Co-Promoter Liability.

Published in:

Defense Counsel Journal, 2015, v. 82, n. 3, p. 295, doi. 10.12690/0895-0016-82.3.295

By:

Lasker, Eric G.;
Klein, Stephen A.;
Barago, Tamara Fishman

Publication type:

Article

Overcoming Tensions between Drug/Device Defendants and Treating Physicians.

Published in:

Defense Counsel Journal, 2014, v. 81, n. 3, p. 294

By:

Yates, Pamela;
Anziska, Evan;
William Bates, Walter;
Adams, Allison

Publication type:

Article

Predictors of verdict and punitive damages in high-stakes civil litigation.

Published in:

Behavioral Sciences & the Law, 2008, v. 26, n. 2, p. 167, doi. 10.1002/bsl.807

By:

Vinson, Katherine V.;
Costanzo, Mark A.;
Berger, Dale E.

Publication type:

Article

Essencialidade e assistência farmacêutica: considerações sobre o acesso a medicamentos mediante ações judiciais no Brasil.

Published in:

Pan American Journal of Public Health, 2011, v. 29, n. 2, p. 138, doi. 10.1590/S1020-49892011000200010

By:

Sant'Ana, João Maurício Brambati;
Pepe, Vera Lúcia Edais;
Osorio-de-Castro, Claudia Garcia Serpa;
Ventura, Miriam

Publication type:

Article

From the Alabama Supreme Court.

Published in:: Alabama Lawyer, 2014, v. 75, n. 6, p. 400
Publication type:: Article

A Hard Pill to Swallow: A Critical Look at Eli Lilly & Co.'s NAFTA Challenge of the Canadian Patent Regime, and Its Potential Side Effects.

Published in:

International Lawyer, 2013, v. 47, n. 3, p. 519

By:

HAKERT II, J. DAMIAN

Publication type:

Article

PAY-FOR-DELAY SETTLEMENTS IN THE WAKE OF ACTAVIS.

Published in:

Michigan Telecommunications & Technology Law Review, 2014, v. 20, n. 2, p. 523

By:

Fialkoff, Michael L.

Publication type:

Article

The curious case of India’s Bolar provision.

Published in:

Journal of Generic Medicines, 2018, v. 14, n. 1, p. 16, doi. 10.1177/1741134317745351

By:

Rathod, Sandeep K.

Publication type:

Article

Pharmaceutical; Trademark; Patents; News.

Published in:

Journal of Generic Medicines, 2014, v. 11, n. 1/2, p. 78, doi. 10.1177/1741134314557911

By:

Milchior, Richard;
Charbonnel, Séverine

Publication type:

Article

Bayer Healthcare Pharmaceuticals, Inc. v. Watson Pharmaceuticals, Inc.: Was the decision to selectively present evidence of commercial success too “clever by half”?

Published in:

2013

By:

Rein, Frederick H;
Crystal, Joseph B

Publication type:

Case Study

EU Legal and Regulatory Update.

Published in:

Journal of Generic Medicines, 2010, v. 7, n. 2, p. 211, doi. 10.1057/jgm.2010.5

By:

Milchior, Richard;
Benattar, Estelle

Publication type:

Article

Recent cases highlight shortcomings and inconsistencies in the law: In re Ciprofloxacin; Celgene v. KV and SB Pharmco v. Mutual.

Published in:

Journal of Generic Medicines, 2009, v. 6, n. 2, p. 167, doi. 10.1057/jgm.2008.37

By:

Majiduddin, Fahd K;
Braier, Paul A

Publication type:

Article

Arbitrating Commercial Healthcare Disputes: The Good, the Bad and the Unknown.

Published in:

Dispute Resolution Journal, 2007, v. 62, n. 4, p. 21

By:

Lash, Alan D.

Publication type:

Article

Square Peg in a Round Hole: Two Recent Cases Show Potential Limitations for States in AWP Litigation.

Published in:

Journal of Health Care Compliance, 2010, v. 12, n. 3, p. 55

By:

Makwana, Kashmira

Publication type:

Article

Patents or patients?

Published in:: 2013
Publication type:: Opinion

Patent battle decisive.

Published in:: 2012
Publication type:: Opinion

SAY HELLO TO MY LITTLE FRIEND CIVIL RICO: THE THIRD CIRCUIT GREEN LIGHTS INSURANCE SHAKEDOWN OF BIG PHARMA WITH IN RE AVANDIA.

Published in:

Villanova Law Review, 2016, v. 61, n. 4, p. 625

By:

BUSSEY-GARZA, MARIE

Publication type:

Article

News and Notes: Compiled by Robert Calder and Jean O'Reilly.

Published in:: Addiction, 2019, v. 114, n. 8, p. 1509, doi. 10.1111/add.14704
Publication type:: Article

WHY THE "SCOPE OF THE PATENT" TEST CANNOT SOLVE THE DRUG PATENT SETTLEMENT PROBLEM.

Published in:

Stanford Technology Law Review, 2012, p. 1

By:

Carrier, Michael A.

Publication type:

Article

List of Villains Grows, Along With Determination of Local Prosecutors.

Published in:

Appalachian Journal, 2018, v. 46, n. 1/2, p. 20

By:

Stockton, Shaina

Publication type:

Article

Civil Litigation and the Opioid Epidemic: The Role of Courts in a National Health Crisis.

Published in:

Journal of Law, Medicine & Ethics, 2018, v. 46, n. 2, p. 351, doi. 10.1177/1073110518782945

By:

Gluck, Abbe R.;
Hall, Ashley;
Curfman, Gregory

Publication type:

Article

THE STAY DILEMMA: EXAMINING BRAND AND GENERIC INCENTIVES FOR DELAYING THE RESOLUTION OF PHARMACEUTICAL PATENT LITIGATION.

Published in:

Columbia Law Review, 2011, v. 111, n. 8, p. 1788

By:

Herman, Michael R.

Publication type:

Article

CJEU Santen: No more SPC protection for new indications and new galenic formulations?

Published in:

Journal of Intellectual Property Law & Practice, 2021, v. 16, n. 7, p. 705, doi. 10.1093/jiplp/jpaa216

By:

Stief, Marco;
Wenzel, Robert

Publication type:

Article

MYLAN V. WARNER CHILCOTT: A STUDY IN PHARMACEUTICAL PRODUCT HOPPING.

Published in:

Marquette Intellectual Property Law Review, 2015, v. 19, n. 2, p. 245

By:

IYENGAR, VIKRAM

Publication type:

Article

Death by 1000 Lawsuits: The Public Litigation in Response to the Opioid Crisis Will Mirror the Global Tobacco Settlement of the 1990s.

Published in:

New England Law Review, 2019, v. 52, n. 1, p. 69

By:

Keenan, Paul L.

Publication type:

Article

Report on the Judgments of the CJEU (Fourth Chamber) of 19 January 2017 in Case C-282/15 Queisser Pharma GmbH & Co. KG v. Germany and CJEU (First Chamber) of 27 April 2017 in Case C-672/15 Noria Distributions SARL.

Published in:

European Food & Feed Law Review, 2018, v. 13, n. 1, p. 34

By:

Hiller, Benjamin

Publication type:

Article

Illegal Use of Unauthorized Health Claims Stating Reduced Risk of Contracting a Disease.

Published in:

European Food & Feed Law Review, 2015, v. 10, n. 2, p. 135

By:

Vavrečka, Jan;
Grmelová, Nicole

Publication type:

Article

WHEN TRUTH CANNOT BE PRESUMED: THE REGULATION OF DRUG PROMOTION UNDER AN EXPANDING FIRST AMENDMENT.

Published in:

2014

By:

ROBERTSON, CHRISTOPHER

Publication type:

Essay

REGULATION OF CHANNELS OF DISTRIBUTION.

Published in:

Journal of Marketing, 1979, v. 43, n. 1, p. 84

By:

Werner, Ray O.;
Knapp, Robert W.

Publication type:

Article

Valuing the Residual Intellectual Property in Mature Pharmaceutical Products.

Published in:

European Journal of Risk Regulation, 2018, v. 9, n. 2, p. 337, doi. 10.1017/err.2018.28

By:

ROZEK, Richard P.

Publication type:

Article

Authors’ Reply to Bayer’s Response to “Potential for Conflict of Interest in the Evaluation of Suspected Adverse Drug Reactions: Use of Cerivastatin and Risk of Rhabdomyolysis”.

Published in:

JAMA: Journal of the American Medical Association, 2004, v. 292, n. 21, p. 2658, doi. 10.1001/jama.292.21.2658

By:

Psaty, Bruce M.;
Furberg, Curt D.;
Ray, Wayne A.;
Weiss, Noel S.

Publication type:

Article

Bayer’s Response to “Potential for Conflict of Interest in the Evaluation of Suspected Adverse Drug Reactions: Use of Cerivastatin and Risk of Rhabdomyolysis”.

Published in:

JAMA: Journal of the American Medical Association, 2004, v. 292, n. 21, p. 2655, doi. 10.1001/jama.292.21.2655

By:

Piorkowski, Joseph D.

Publication type:

Article

The I.G. Farben Trial: Evidentiary Standards and Procedures and the Problem of Creating Legitimacy.

Published in:

Harvard International Law Journal, 2020, v. 61, n. 1, p. 245

By:

Brudney, Allie

Publication type:

Article

COLACICCO V APOTEX INC. AND THE FEDERAL PREEMPTION OF STATE TORT REMEDIES FOR HEALTH INJURIES: IMPLICATIONS FOR PUBLIC HEALTH POLICY AND PRACTICE.

Published in:

Public Health Reports, 2009, v. 124, n. 1, p. 160, doi. 10.1177/003335490912400119

By:

Burke, Taylor

Publication type:

Article

Gaeta v. Perrigo Pharm. Co.

Published in:: Urban Lawyer, 2011, v. 43, n. 4, p. 1119
Publication type:: Article

Settling High: A Common Law Public Nuisance Response to the Opioid Epidemic.

Published in:

Columbia Journal of Law & Social Problems, 2018, v. 52, n. 1, p. 135

By:

PURCELL, MICHAEL J.

Publication type:

Article

Inference or Evidence? The Uncertain Fate of Patent Settlement Agreements.

Published in:

Journal of European Competition Law & Practice, 2018, v. 9, n. 7, p. 449, doi. 10.1093/jeclap/lpy044

By:

Chowdhury, Avantika;
Jenkins, Helen

Publication type:

Article

The Application of EU Competition Law in the Pharmaceutical Sector.

Published in:

Journal of European Competition Law & Practice, 2016, v. 7, n. 2, p. 150, doi. 10.1093/jeclap/lpv093

By:

Hull, David W.;
Clancy, Michael J.

Publication type:

Article

Astrazeneca: Court of Justice Upholds First Decision Finding Abuse of Dominant Position in Pharmaceutical Sector.

Published in:

Journal of European Competition Law & Practice, 2013, v. 4, n. 3, p. 228, doi. 10.1093/jeclap/lpt009

By:

Van Malleghem, Pieter-Augustijn;
Devroe, Wouter

Publication type:

Article

WHEN THE MATH MATTERS: USE OF P-VALUES IN PHARMACEUTICAL LITIGATION.

Published in:

Vermont Law Review, 2023, v. 48, n. 2, p. 153

By:

Juni, Robin L.

Publication type:

Article

Ranbaxy censured by FDA over falsified data.

Published in:: Nature, 2009, v. 458, n. 7234, p. 20, doi. 10.1038/458020d
Publication type:: Article

Addicted to secrecy.

Published in:: 2007
Publication type:: Editorial

REVERSE SETTLEMENTS AS PATENT INVALIDITY SIGNALS.

Published in:

Harvard Journal of Law & Technology, 2011, v. 24, n. 2, p. 281

By:

Dolin, Gregory;
M. D.

Publication type:

Article

FEDERAL JURISDICTION OVER CLAIMS BY STATE ATTORNEYS GENERAL: THE CASE FOR REMOVAL OF PHARMACEUTICAL PARENS PATRIAE SUITS AS "MASS ACTIONS™ UNDER THE CLASS ACTION FAIRNESS ACT OF 2005.

Published in:

Health Law & Policy, 2014, v. 7, n. 2, p. 1

By:

McIntire, Amy

Publication type:

Article

COMBATTING THE OPIOID EPIDEMIC IN TEXAS BY HOLDING BIG PHARMA MANUFACTURERS LIABLE.

Published in:

St. Mary's Law Journal, 2019, v. 50, n. 4, p. 1353

By:

RIOS, KATHERINE SPISER

Publication type:

Article

DISTRIBUTIVE JUSTICE IN PHARMACEUTICAL TORTS: JUSTICE WHERE JUSTICE IS DUE?

Published in:

Law & Contemporary Problems, 2006, v. 69, n. 4, p. 207

By:

Chen-Sen Wu

Publication type:

Article

A Trojan Horse Inside the Gates? Knowledge Spillovers During Patent Litigation.

Published in:

Academy of Management Journal, 2022, v. 65, n. 5, p. 1747, doi. 10.5465/amj.2018.1181

By:

Awate, Kiran S.;
Makhija, Mona

Publication type:

Article

Medical Advice from Lawyers: A Content Analysis of Advertising for Drug Injury Lawsuits.

Published in:

American Journal of Law & Medicine, 2015, v. 41, n. 1, p. 7, doi. 10.1177/0098858815591508

By:

Tippett, Elizabeth

Publication type:

Article

Being Neighbourly: Canada Welcomes Foreign Defendants in Class Proceedings.

Published in:

FDCC Quarterly, 2015, v. 64, n. 2, p. 177

By:

Neave, David T.

Publication type:

Article

TRADE SECRET RISING: PROTECTING EQUIVALENCY TEST RESEARCH AND DEVELOPMENT INVESTMENTS AFTER MOMENTA V. AMPHASTAR.

Published in:

Journal of Intellectual Property Law, 2014, v. 22, n. 1, p. 209

By:

Rogers, Hannah-Alise

Publication type:

Article